PlantArcBio

Company Overview

Snapshot

Founded in May 2014 by Dror Shalitin, PlantArcBio operates with 11–50 employees. The company has raised $11.15M across three funding rounds and went public on TASE in January 2021. In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia to advance high-yield, drought-resilient corn in South America.

Business overview

PlantArcBio specializes in gene discovery and RNA interference (RNAi) technologies for agricultural applications. The company leverages its proprietary DIP™ (Direct-In-Plant) and DIPPER™ platforms to identify and develop novel genes and gene-editing targets. These technologies aim to enhance crop traits such as yield, drought tolerance, nutrition, and resistance to herbicides and pests. PlantArcBio also develops RNAi-based biological products as sustainable alternatives for crop protection, serving the agriculture and food technologies sector by improving plant resilience and productivity for climate-adaptive farming practices.

Strategic signal

In February 2026, PlantArcBio announced a significant licensing collaboration with Helix Sementes e Biotecnologia, a company within the Agroceres Group, to advance high-yield, drought-resilient corn in South America. This partnership signals strong market validation for PlantArcBio's precision biology platforms and demonstrates a clear strategic move towards expanding its climate-resilient agricultural solutions into key global markets, indicating potential for increased revenue and market penetration.

Company Intelligence Q&A

When did PlantArcBio go public?

PlantArcBio went public on the TASE in January 2021.

What was a significant recent partnership for PlantArcBio?

In February 2026, PlantArcBio announced a licensing collaboration with Helix Sementes e Biotecnologia, a company within the Agroceres Group, to develop high-yield, drought-resilient corn in South America.

Has PlantArcBio received any recent patent approvals?

In September 2025, PlantArcBio secured patents in the United States and South Korea for its proprietary DIPPER™ platform, advancing gene-editing optimization in crops.

What strategic collaboration did PlantArcBio form in December 2024?

In December 2024, ToolGen and PlantArcBio forged a strategic collaboration to develop gene-edited, herbicide-tolerant soybeans for global markets.

When did PlantArcBio receive USDA-APHIS approval for its herbicide-tolerant gene?

In January 2024, PlantArcBio received USDA-APHIS approval in the US for planting and breeding soybean modified with its novel PPO herbicide-tolerant gene.